Browse > Article
http://dx.doi.org/10.7314/APJCP.2014.15.8.3519

Comparative Analysis of Oct4 in Different Histological Subtypes of Esophageal Squamous Cell Carcinomas in Different Clinical Conditions  

Vaiphei, Kim (Department of Histopathology, Post Graduate Institute of Medical Education and Research)
Sinha, Saroj Kant (Department of Gastroenterology, Post Graduate Institute of Medical Education and Research)
Kochhar, Rakesh (Department of Gastroenterology, Post Graduate Institute of Medical Education and Research)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.15, no.8, 2014 , pp. 3519-3524 More about this Journal
Abstract
Background: Esophageal squamous cell carcinoma (ESCC) is a common cancer with poor prognosis. It has been hypothesized that Oct4 positive radioresistant stem cells may be responsible for tumor recurrence. Hence, we evaluated Oct4 expression in ESCC in pre-treatment, post neo-adjuvant residual and post-surgical recurrent tumours. Materials and Methods: Endoscopic mucosal biopsies were used to study Oct4 expression and the observations were correlated with histological tumor grades, patient data and clinical background. Results: All patients presented with dysphagia with male predominance and a wide age range. Majority of the patients had intake of mixed diet, history of alcohol and tobacco intake was documented in less than half of the patients. Oct 4 expression was significantly higher in poorly differentiated (PDSCC) and basaloid (BSCC) subtypes than the other better differentiated tumor morphology. Oct4 was also expressed by adjoining esophageal mucosa showing low grade dysplasia and basal cell hyperplasia (BCH). Biopsies in PDSCC and BSCC groups were more likely to show a positive band for Oct4 by polymerase chain reaction (PCR). Dysplasia and BCH mucosa also showed Oct4 positivity by PCR. All mucosal biopsies with normal morphology were negative for Oct4. Number of tissue samples showing Oct4 positivity by PCR was higher than that by the conventional immunohistochemistry (p>0.05). Oct4 expression pattern correlated only with tumor grading, not with other parameters including the clinical background or patient data. Conclusions: Our observations highlighted a possible role of Oct4 in identifying putative cancer stem cells in ESCC pathobiology and response to treatment. The implications are either in vivo existence of Oct4 positive putative cancer stem cells in ESCC or acquisition of cancer stem cell properties by tumor cells as a response to treatment given, resulting ultimately an uncontrolled cell proliferation and treatment failure.
Keywords
Esophageal squamous cell carcinoma; Oct4; cancer stem cell;
Citations & Related Records
Times Cited By KSCI : 4  (Citation Analysis)
연도 인용수 순위
1 Rosenthal DT, Zhang J, Bao L, et al (2012). RhoC impacts the metastatic potential and abundance of breast cancer stem cells. PLoS One, 7, e40979.   DOI
2 Huang D, Gao Q, Guo L, et al (2009). Isolation and identification of cancer stem-like cells in esophageal carcinoma cell lines. Stem Cells, 18, 465-73.   DOI   ScienceOn
3 Hochedlinger K, Yamada Y, Beard C, Jaenisch R (2005). Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues. Cell, 121, 465-77.   DOI   ScienceOn
4 Hu T, Liu S, Breiter DR, et al (2008). Octamer 4 small interfering RNA results in cancer stem cell-like cell apoptosis. Cancer Res, 68, 6533-40.   DOI   ScienceOn
5 Huang CP, Tsai MF, Chang TH, et al (2013). ALDH-positive lung cancer stem cells confer resistance to epidermal growth factor receptor tyrosine kinase inhibitors. Cancer Lett, 328, 144-51.   DOI   ScienceOn
6 ICMR (2002). National cancer registry programme, 1981-2001, an overview. Indian council of medical research, New Delhi.
7 Ilett EJ, Prestwich RJ, Melcher AA (2010).The evolving role of dendritic cells in cancer therapy. Expert Opin Biol Ther, 10, 369.   DOI   ScienceOn
8 Islam M, Sharma S, Teknos TN (2014). RhoC regulates cancer stem cells in head and neck squamous cell carcinoma by overexpressing IL-6 and phosphorylation of STAT3. PLoS One, 9, e88527.   DOI   ScienceOn
9 Jones T, Ulbright T, Eble J, Baldridge L, Cheng L (2004). OCT4 staining in testicular tumors: a sensitive and specific marker for seminoma and embryonal carcinoma. Am J Surg Pathol, 28, 935-40.   DOI   ScienceOn
10 Katona TM, Billings SD, Montironi R, Lopez-Beltran A, Cheng L (2007). Expression of OCT4 transcription factor in cutaneous neoplasia. Appl Immunohistochem Mol Morphol, 15, 359-62.   DOI   ScienceOn
11 Kim MC, Cui FJ, Kim Y (2013). Hydrogen peroxide promotes epithelial to mesenchymal transition and stemness in human malignant mesothelioma cells. Asian Pac J Cancer Prev, 14, 3625-30.   과학기술학회마을   DOI   ScienceOn
12 Cheng L, Sung MT, Cossu-Rocca P, et al (2007). OCT4:biological functions and clinical applications as a marker of germ cell neoplasia. J Pathol, 211, 1-9.   DOI   ScienceOn
13 Campbell NP, Villaflor VM (2010). Neoadjuvant treatment of esophageal cancer. World J Gastroenterol, 16, 3793-803.   DOI
14 Cauffman G, Liebaers I, Van Steirteghem A, Van de Velde H (2006). POU5F1 isoforms show different expression patterns in human embryonic stem cells and preimplantation embryos. Stem Cells, 24, 2685-91.   DOI   ScienceOn
15 Chen Z, Xu WR, Qian H, et al (2009). Oct4, a novel marker for human gastric cancer. J Surg Oncol, 99, 414-9.   DOI   ScienceOn
16 Enzinger PC, Mayer RJ (2003). Esophageal cancer. N Engl J Med, 349, 2241-52.   DOI   ScienceOn
17 Forte A, Schettino MT, Finicelli M, et al (2009). Expression pattern of stemness-related genes in human endometrial and endometriotic tissue. Mol Med, 15, 392-401.
18 Gao JX (2008). Cancer stem cells: the lessons from precancerous stem cells. J Cell Mol Med, 12, 67-96.
19 Ghisolfi L, Keates AC, Hu X, Lee D-k, Li CJ (2012). Ionizing radiation induces stemness in cancer cells. PLoS, 7, 43628.   DOI
20 He W, Li K, Wang F, Qin YR, Fan QX (2012). Expression of OCT4 in human esophageal squamous cell carcinoma is significantly associated with poorer prognosis. World J Gastroenterol, 18, 712-9.   DOI   ScienceOn
21 He W, Li K, Wang F, Qin YR, Fan QX (2012). Expression of OCT4 in human esophageal squamous cell carcinoma is significantly associated with poorer prognosis. World J Gastroenterol, 18, 712-9.   DOI   ScienceOn
22 Hochedlinger K, Plath K (2009). Epigenetic reprogramming and induced pluripotency. Development, 136, 509.   DOI   ScienceOn
23 Atlasi Y, Mowla SJ, Ziaee SA, Bahrami AR (2006). OCT-4, an embryonic stem cell marker, is highly expressed in bladder cancer. Int J Cancer, 120, 1598-602.
24 Atlasi Y, Mowla SJ, Ziaee SA, Gokhale PJ, Andrews PW (2008). OCT4 spliced variants are differentially expressed in human pluripotent and nonpluripotent cells. Stem Cell, 26, 3068-74.   DOI   ScienceOn
25 Bahl K, Saraya A, Sharma R (2012). Increased levels of circulating and tissue mRNAs of Oct-4, sox-2, Bmi-1 and nanog is escc patients: potential tool for minimally invasive cancer diagnosis. Biomarker Insights, 7, 27-37.
26 Huang CP, Tsai MF, Chang TH, et al (2013). ALDH positive lung cancer stem cells confer resistance to epidermal growth factor receptor tyrosine kinase inhibitors. Cancer Lett, 328, 144-51.   DOI   ScienceOn
27 Zhou H, Ding S (2010). Evolution of induced pluripotent stem cell technology. Curr Opin Hematol, 17, 276.   DOI   ScienceOn
28 Zhang X, Komaki R, Wang L, Fang B, Chang JY (2008). Treatment of radioresistant stem-like esophageal cancer cells by an apoptotic gene-armed, telomerase-specific oncolytic adenovirus. Clin Cancer Res, 14, 2813-23.   DOI   ScienceOn
29 Zhou GX, Li XY, Zhang Q, et al (2013). Effects of the hippo signaling pathway in human gastric cancer. Asian Pac J Cancer Prev, 14, 5199-205.   과학기술학회마을   DOI   ScienceOn
30 Wang QI, Hei W, Lu C, et al (2009). Oct3/4 and Sox2 are significantly associated with an unfavorable clinical outcome in human esophageal squamous cell carcinoma. Anticancer Res, 29, 1233-42.
31 Sanada Y, Yoshida K, Ohara M, et al (2006). Histopathologic evaluation of stepwise progression of pancreatic carcinoma with immunohistochemical analysis of gastric epithelial transcription factor SOX2: comparison of expression patterns between invasive components and cancerous or nonneoplastic intraductal components. Pancreas, 32, 164-70.   DOI   ScienceOn
32 Tai MH, Chang CC, Olson KL, Trosko JE (2005). Oct4 expression in adult human stem cells: evidence in support of the stem cell theory of carcinogenesis. Carcinogenesis, 26, 495-502.
33 Warren L, Manos PD, Ahfeldt T, et al (2010). Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell, 7, 618.   DOI   ScienceOn
34 Warthemann R, Eildermann K, Debowski K, Behr R (2012). False-positive antibody signals for the pluripotency factor OCT4A (POU5F1) in testis-derived cells may lead to erroneous data and misinterpretations. Mol Hum Reprod, 18, 605-12.   DOI
35 Wicha MS (2014). Targeting self-renewal, an Achilles’ heel of cancer stem cells. Nat Med, 20, 14-5.   DOI   ScienceOn
36 Xi Z, Guang-Rong H, Pin H (2011). Over-expression of Oct4 in human esophageal squamous cell carcinoma. Mol Cells, 32, 39-45.   DOI   ScienceOn
37 Lee J, Kim HK, Rho JY, Han YM, Kim J (2006). The human OCT-4 isoforms differ in their ability to confer self-renewal. J Biol Chem, 281, 33554-65.   DOI   ScienceOn
38 Zangrossi S, Marabese M, Broggini M, et al (2007). Oct-4 expression in adult human differentiated cells challenges its role as a pure stem cell marker. Stem Cells, 25, 1675-80.   DOI   ScienceOn
39 Li X, Wang J, Xu Z, et al (2012). Expression of Sox2 and Oct4 and their clinical significance in human non-small-cell lung cancer. Int J Mol Sci, 13, 7663-75.   DOI
40 Koukourakis MI, Giatromanolaki A, Tsakmaki V, Danielidis V, Sivridis E (2012). Cancer stem cell phenotype relates to radio-chemotherapy outcome in locally advanced squamous cell head-neck cancer. Br J Cancer, 106, 846-53.   DOI   ScienceOn
41 Li MH, Li P, Li PJ (1980). Recent progress in research on esophageal cancer in China. Adv Cancer Res, 33,173-249.   DOI
42 Matthai C, Horvat R, Noe M, et al (2006). Oct-4 expression in human endometrium. Mol Hum Reprod, 12, 7-10.   DOI   ScienceOn
43 Monk M, Holding C (2001). Human embryonic genes reexpressed in cancer cells. Oncogene, 20, 8085-91.   DOI   ScienceOn
44 Nichols J, Zevnik B, Anastassiadis K, et al (1998). Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell1, 95, 379-91.   DOI   ScienceOn
45 Parkin DM, Bray F, Ferlay J, Pisani P (2001). Estimates of the world cancer burden: globocan 2000. Int J Cancer, 94, 153-6.   DOI   ScienceOn
46 Parkin DM, Bray F, Ferlay J, Pisani P (2005). Global cancer statistics, 2002. CA Cancer J Clin, 55, 74-108.   DOI   ScienceOn
47 Niwa H, Miyazaki J, Smith AG (2000). Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or selfrenewal of ES cells. Nat Genet, 24, 372-6.   DOI   ScienceOn
48 Zhang AM, Fan Y, Yao Q, et al (2012). Identification of a cancer stem-like population in the Lewis lung cancer cell line. Asian Pac J Cancer Prev, 13, 761-6.   과학기술학회마을   DOI   ScienceOn